Phase 2b Study of ASP015K - A Double-Blind, Placebo-Controlled, Dose-Finding Study in Moderate to Severe Rheumatoid Arthritis Patients
Latest Information Update: 07 Nov 2021
At a glance
- Drugs Peficitinib (Primary)
- Indications Rheumatoid arthritis
- Focus Therapeutic Use
- Acronyms RAJ1
- Sponsors Astellas Pharma
- 15 Dec 2015 Results published in the Annals of the Rheumatic Diseases.
- 26 Jul 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 08 Jul 2013 Status changed from recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.